IN8bio (INAB) Earnings Date & Reports

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INAB is expected to report earnings to fall 51.09% to -34 cents per share on August 06

Q2'26

Est.

$-0.34

Q4'25

Missed

by $0.65

Q3'25

Missed

by $0.80

Q2'25

Missed

by $1.18

Q1'25

Est.

$-0.07

The last earnings report on March 12 showed earnings per share of -69 cents, missing the estimate of -4 cents. With 7.79K shares outstanding, the current market capitalization sits at 14.05M.

View a ticker or compare two or three

Compare

INAB

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for INAB